Augmedix Stock Price, News & Analysis (OTCMKTS:AUGX) $5.28 +0.13 (+2.52%) (As of 11/30/2023 ET) Add Compare Share Share Today's Range$5.06▼$5.3250-Day Range$4.34▼$5.7252-Week Range$1.01▼$5.97Volume199,348 shsAverage Volume443,001 shsMarket Capitalization$218.40 millionP/E RatioN/ADividend YieldN/APrice Target$6.83 Stock AnalysisStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC Filings Augmedix MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside29.4% Upside$6.83 Price TargetShort InterestN/ADividend StrengthN/ASustainabilityN/ANews Sentiment0.27Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.48) to ($0.36) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.08 out of 5 stars 3.5 Analyst's Opinion Consensus RatingAugmedix has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $6.83, Augmedix has a forecasted upside of 29.4% from its current price of $5.28.Amount of Analyst CoverageAugmedix has received no research coverage in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for AUGX. Previous Next 0.0 Dividend Strength Dividend YieldAugmedix does not currently pay a dividend.Dividend GrowthAugmedix does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AUGX. Previous Next 2.4 News and Social Media Coverage News SentimentAugmedix has a news sentiment score of 0.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.76 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Augmedix this week, compared to 1 article on an average week.Search Interest7 people have searched for AUGX on MarketBeat in the last 30 days. This is an increase of 133% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Augmedix insiders have not sold or bought any company stock.Percentage Held by Insiders10.97% of the stock of Augmedix is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions71.58% of the stock of Augmedix is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Augmedix are expected to grow in the coming year, from ($0.48) to ($0.36) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Augmedix is -9.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Augmedix is -9.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAugmedix has a P/B Ratio of 52.80. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Augmedix Stock (OTCMKTS:AUGX)Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Notes that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, a self-service mobile software application. The company enables clinicians to access its applications through mobile devices, such as smartphones or Google Glass. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.Read More AUGX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AUGX Stock News HeadlinesNovember 27, 2023 | msn.comAugmedix (AUGX) Price Target Increased by 7.60% to 7.82November 24, 2023 | uk.finance.yahoo.comAugmedix, Inc. (AUGX)December 1, 2023 | DTI Trader (Ad)New CBOE “special perk” helps traders target income every weekendYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. November 16, 2023 | investorplace.comWhy Is Augmedix (AUGX) Stock Down 27% Today?November 15, 2023 | finance.yahoo.comAugmedix Announces Proposed Public Offering of 5,500,000 Shares of Common StockNovember 10, 2023 | finance.yahoo.comHow Much Upside is Left in Augmedix, Inc. (AUGX)? Wall Street Analysts Think 36.67%November 9, 2023 | finance.yahoo.comAnalyst Estimates: Here's What Brokers Think Of Augmedix, Inc. (NASDAQ:AUGX) After Its Third-Quarter ReportNovember 7, 2023 | finance.yahoo.comAugmedix, Inc. (NASDAQ:AUGX) Q3 2023 Earnings Call TranscriptDecember 1, 2023 | DTI Trader (Ad)New CBOE “special perk” helps traders target income every weekendYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. October 9, 2023 | finance.yahoo.comGetting In Cheap On Augmedix, Inc. (NASDAQ:AUGX) Might Be DifficultOctober 4, 2023 | msn.comAugmedix: Using Generative AI To Document Medical RecordsSeptember 21, 2023 | finance.yahoo.comAugmedix, Inc. (AUGX) is on the Move, Here's Why the Trend Could be SustainableSeptember 12, 2023 | msn.comAre Medical Stocks Lagging Augmedix (AUGX) This Year?September 12, 2023 | finance.yahoo.comAre Medical Stocks Lagging Augmedix (AUGX) This Year?September 5, 2023 | finance.yahoo.comRecent Price Trend in Augmedix, Inc. (AUGX) is Your Friend, Here's WhyAugust 24, 2023 | finance.yahoo.comIs Artivion (AORT) Outperforming Other Medical Stocks This Year?August 24, 2023 | finance.yahoo.comAugmedix Achieves HITRUST Certification to Further Mitigate Risk in Third-Party Privacy, Security and ComplianceAugust 18, 2023 | finance.yahoo.comAugmedix Announces Participation in Upcoming Investor Conferences in September 2023August 16, 2023 | finance.yahoo.comAugmedix, Inc. (AUGX) Is a Great Choice for 'Trend' Investors, Here's WhyAugust 16, 2023 | finance.yahoo.comWall Street Analysts See a 32.11% Upside in Augmedix, Inc. (AUGX): Can the Stock Really Move This High?August 9, 2023 | markets.businessinsider.comB.Riley Financial Keeps Their Buy Rating on Augmedix (AUGX)August 8, 2023 | finance.yahoo.comWhy Shares of Augmedix Are Climbing on TuesdayAugust 8, 2023 | finanznachrichten.deAugmedix Inc: Augmedix Delivers 47% Revenue Growth and Expanded Gross Margins for Second Quarter of 2023August 8, 2023 | finance.yahoo.comAugmedix Delivers 47% Revenue Growth and Expanded Gross Margins for Second Quarter of 2023August 8, 2023 | finance.yahoo.comAugmedix, Inc. (AUGX) Reports Q2 Loss, Tops Revenue EstimatesAugust 4, 2023 | benzinga.comAugmedix's Earnings: A PreviewJuly 28, 2023 | finance.yahoo.comAugmedix to Announce Second Quarter 2023 Financial Results and Host Investor Conference Call on August 7, 2023See More Headlines Receive AUGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Augmedix and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/06/2023Today11/30/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Health Information Services Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:AUGX CUSIPN/A CIK1769804 Webwww.augmedix.com Phone888-669-4885FaxN/AEmployees1,040Year FoundedN/APrice Target and Rating Average Stock Price Target$6.83 High Stock Price Target$8.00 Low Stock Price Target$6.00 Potential Upside/Downside+29.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.51) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-24,450,000.00 Net Margins-57.70% Pretax Margin-57.23% Return on Equity-980.09% Return on Assets-57.85% Debt Debt-to-Equity Ratio3.74 Current Ratio1.70 Quick Ratio1.70 Sales & Book Value Annual Sales$40.93 million Price / Sales5.34 Cash FlowN/A Price / Cash FlowN/A Book Value$0.10 per share Price / Book52.80Miscellaneous Outstanding Shares41,364,000Free Float36,316,000Market Cap$218.40 million OptionableNot Optionable Beta-0.38 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Emmanuel Krakaris (Age 64)President, CEO, Secretary & Director Comp: $734.33kMr. Ian Shakil (Age 38)Founder, Chief Strategy Officer & Director Ms. Sandra Breber (Age 65)Chief Operating Officer Comp: $446.05kMr. Saurav Chatterjee Ph.D. (Age 51)Chief Technology Officer Comp: $438.05kMr. Paul Louis Ginocchio (Age 53)Chief Financial Officer Todd HolvickHead of Legal & ComplianceLia WallickHead of PeopleDr. Davin Lundquist M.D.Chief Medical OfficerMr. Jonathan Hawkins (Age 53)Chief Revenue Officer Comp: $417.71kMore ExecutivesKey CompetitorsTabula Rasa HealthCareNASDAQ:TRHCNutex HealthNASDAQ:NUTXForianNASDAQ:FORAKamadaNASDAQ:KMDAEyePoint PharmaceuticalsNASDAQ:EYPTView All CompetitorsInsidersMargie L TraylorBought 26,530 shares on 6/14/2023Total: $119,650.30 ($4.51/share)View All Insider Transactions AUGX Stock Analysis - Frequently Asked Questions Should I buy or sell Augmedix stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Augmedix in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AUGX shares. View AUGX analyst ratings or view top-rated stocks. What is Augmedix's stock price target for 2024? 3 brokerages have issued 1 year price objectives for Augmedix's shares. Their AUGX share price targets range from $6.00 to $8.00. On average, they anticipate the company's share price to reach $6.83 in the next twelve months. This suggests a possible upside of 29.4% from the stock's current price. View analysts price targets for AUGX or view top-rated stocks among Wall Street analysts. How have AUGX shares performed in 2023? Augmedix's stock was trading at $1.56 on January 1st, 2023. Since then, AUGX shares have increased by 238.5% and is now trading at $5.28. View the best growth stocks for 2023 here. How were Augmedix's earnings last quarter? Augmedix, Inc. (OTCMKTS:AUGX) posted its quarterly earnings data on Monday, November, 6th. The company reported ($0.10) earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.02. The firm earned $11.77 million during the quarter, compared to the consensus estimate of $11.41 million. Augmedix had a negative trailing twelve-month return on equity of 980.09% and a negative net margin of 57.70%. How do I buy shares of Augmedix? Shares of AUGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (OTCMKTS:AUGX) was last updated on 12/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Augmedix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.